JOEL H HERRING M.D.
Prescription History 1831286699
Ophthalmology - Retina Specialist in Jackson, MS


Quality Rating: 100 out of 100 score

NPI Status: Active since October 05, 2006

Contact Information

1200 N STATE ST
SUITE 300
JACKSON, MS
ZIP 39202
Phone: (601) 981-4091
Fax: (601) 981-5039

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOEL H HERRING M.D., an active Retina Specialist specialist practicing in Jackson, MS. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,714 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 491 claims alone.


Alphagan P

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 73
30-Day Fills 96.0
Days Supply 2,465
MS State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills46.9
Peer Average Days Supply1,312
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 121.2% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $22,240.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$304.67

State Avg Cost Per Claim

$331.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Atropine Sulfate

Generic Formulation: Atropine SulfateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 11
30-Day Fills 18.0
Days Supply 454
MS State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills29.1
Peer Average Days Supply719
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.2% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $793.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$72.16

State Avg Cost Per Claim

$52.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.

Therapeutic Applications

This medication is used before eye examinations (such as refraction) and to treat certain eye conditions (such as uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.

Brimonidine Tartrate

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 211
30-Day Fills 324.5
Days Supply 9,221
MS State Average Benchmarks
Peer Average Claims67.0
Peer Average 30-Day Fills110.7
Peer Average Days Supply3,155
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 214.9% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,537.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.03

State Avg Cost Per Claim

$32.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Brimonidine Tartrate-Timolol

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 36
30-Day Fills 52.5
Days Supply 1,533
MS State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills25.2
Peer Average Days Supply690
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 100.0% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,724.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$186.80

State Avg Cost Per Claim

$250.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Carteolol Hcl

Generic Formulation: Carteolol HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 297
MS State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills90.8
Peer Average Days Supply2,680
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 73.3% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $221.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.45

State Avg Cost Per Claim

$22.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Carteolol is used alone or with other medications to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. Carteolol is a beta blocker. It is thought to work by reducing the amount of fluid made in the eye.

Combigan

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 161
30-Day Fills 225.0
Days Supply 6,387
MS State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills67.3
Peer Average Days Supply1,890
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 250.0% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $44,159.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$274.29

State Avg Cost Per Claim

$332.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Difluprednate

Generic Formulation: DifluprednateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 18
30-Day Fills 21.7
Days Supply 456
MS State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills43.3
Peer Average Days Supply1,077
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.6% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,705.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$150.33

State Avg Cost Per Claim

$144.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat swelling and pain after eye surgery. It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids.

Dorzolamide Hcl

Generic Formulation: Dorzolamide HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 89
30-Day Fills 175.3
Days Supply 5,256
MS State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills87.0
Peer Average Days Supply2,590
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 81.6% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,158.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.26

State Avg Cost Per Claim

$25.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors.

Dorzolamide-Timolol

Generic Formulation: Dorzolamide Hcl/Timolol MaleatSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 97
30-Day Fills 191.0
Days Supply 5,646
MS State Average Benchmarks
Peer Average Claims81.0
Peer Average 30-Day Fills150.9
Peer Average Days Supply4,496
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,913.25 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.03

State Avg Cost Per Claim

$30.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

Latanoprost

Generic Formulation: LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 227
30-Day Fills 363.4
Days Supply 10,418
MS State Average Benchmarks
Peer Average Claims179.0
Peer Average 30-Day Fills282.1
Peer Average Days Supply7,946
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.8% more claims than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,256.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.35

State Avg Cost Per Claim

$14.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Lumigan

Generic Formulation: BimatoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 26
30-Day Fills 35.9
Days Supply 1,052
MS State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills93.6
Peer Average Days Supply2,642
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.7% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,530.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$328.08

State Avg Cost Per Claim

$394.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Ofloxacin

Generic Formulation: OfloxacinSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 177
30-Day Fills 188.1
Days Supply 4,223
MS State Average Benchmarks
Peer Average Claims76.0
Peer Average 30-Day Fills80.2
Peer Average Days Supply1,601
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 132.9% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,751.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.55

State Avg Cost Per Claim

$19.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.

Therapeutic Applications

This medication is used to treat eye infections. Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 491
30-Day Fills 563.3
Days Supply 13,171
MS State Average Benchmarks
Peer Average Claims104.0
Peer Average 30-Day Fills125.6
Peer Average Days Supply3,063
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 372.1% higher than the standard regional baseline profile for MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,406.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.60

State Avg Cost Per Claim

$50.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Prednisone

Generic Formulation: PrednisoneSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 25
30-Day Fills 29.5
Days Supply 638
MS State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills61.6
Peer Average Days Supply1,095
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.0% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $168.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.74

State Avg Cost Per Claim

$5.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Timolol Maleate

Generic Formulation: Timolol MaleateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 60
30-Day Fills 115.9
Days Supply 3,382
MS State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills114.7
Peer Average Days Supply3,342
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $697.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.63

State Avg Cost Per Claim

$17.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

Therapeutic Applications

This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like JOEL H HERRING M.D. provides transparency into local medical care patterns within Jackson, MS.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Retina Specialist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.